Patents by Inventor Venkat R. Goskonda

Venkat R. Goskonda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Room-temperature stable dronabinol formulations
    Patent number: 8628796
    Abstract: A room temperature stable cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation is dronabinol in an oil-based carrier contained within a hard gelatin capsule.
    Type: Grant
    Filed: December 9, 2005
    Date of Patent: January 14, 2014
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Zhongyuan Zhu, Venkat R. Goskonda
  • SUBLINGUAL FENTANYL SPRAY
    Publication number: 20130327321
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: May 15, 2013
    Publication date: December 12, 2013
    Applicant: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • SUBLINGUAL FENTANYL SPRAY
    Publication number: 20130296368
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable sale thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: May 15, 2013
    Publication date: November 7, 2013
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Sublingual fentanyl spray
    Patent number: 8486973
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: August 1, 2008
    Date of Patent: July 16, 2013
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Sublingual fentanyl spray
    Patent number: 8486972
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Grant
    Filed: January 25, 2007
    Date of Patent: July 16, 2013
    Assignee: Insys Therapeutics, Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Neha Parikh, Linet Kattookaran
  • Liquid cannabinoid formulations
    Patent number: 8222292
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: July 17, 2012
    Assignee: Insys Therapeutics, Inc.
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill
  • LIQUID CANNABINOID FORMULATIONS
    Publication number: 20110306660
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Application
    Filed: August 31, 2011
    Publication date: December 15, 2011
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill
  • Oral cannabinnoid liquid formulations and methods of treatment
    Publication number: 20090181080
    Abstract: A room temperature stable aqueous cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation comprises dronabinol in a mixture of buffer solution, and organic cosolvents such as ethanol, propylene glycol and polyethylene glycol.
    Type: Application
    Filed: August 6, 2008
    Publication date: July 16, 2009
    Applicant: Insys Therapeutics Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran
  • Sublingual fentanyl spray
    Publication number: 20090176834
    Abstract: The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
    Type: Application
    Filed: August 1, 2008
    Publication date: July 9, 2009
    Applicant: Insys Therapeutics Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran, Neha Parikh
  • Aqueous dronabinol formulations
    Publication number: 20080112895
    Abstract: A room temperature stable aqueous cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation comprises dronabinol in a mixture of buffer solution, and organic cosolvents such as ethanol, propylene glycol and polyethylene glycol.
    Type: Application
    Filed: August 6, 2007
    Publication date: May 15, 2008
    Applicant: Insys Therapeutics Inc.
    Inventors: S. George Kottayil, Venkat R. Goskonda, Zhongyuan Zhu, Linet Kattookaran